ORCL

ACCE-researched
Oracle Corporation Common Stock
Technology · Software - Infrastructure · NYSE · United States
$147.61-1.98%
Market cap $446.3BNext earnings 2026-09-10Updated Sep 19, 2026
FAIR VALUE · 6-MODEL CONSENSUS
$147.61+0.0%
confidence-weighted across 6 models
Now $147.61
$147.61
$96.90$225.38
Hold
See plans
Free accounts get 3 full stock pages a month, including FAIR VALUE · 6-MODEL CONSENSUS.
Unlock the ACCE read
See plans
Free accounts get 3 full stock pages a month, including the ACCE read.

ACCE thesis

Oracle sells database software, cloud infrastructure, and enterprise applications-ERP, HCM, and supply chain-to the largest and most compliance-sensitive organizations on earth, where ripping out their stack carries existential risk for the customer. That switching-cost moat, built over four decades of deep schema integrations, lets Oracle extract pricing power while competitors are still fighting for the initial deal. The real catalyst is OCI (Oracle Cloud Infrastructure), which landed a reported $98B backlog as of fiscal Q3 2025, with hyperscaler-grade AI training clusters attracting workloads that AWS and Azure can't accommodate fast enough. Revenue accelerated to 20.6% growth-a rate this company hadn't seen in years-while the forward multiple at 16.1x sits at a meaningful discount to peers growing slower. At a 53.4% ROE and expanding operating margins crossing 36%, the cash generation machine is funding both the capex sprint and continued buybacks, making this a rare case where scale and growth are moving in the same direction simultaneously.

Investor warnings · 4 flags
  • high
    Massive negative FCF
    FCF is -$23.7B, meaning Oracle is burning significant cash despite strong reported earnings, raising questions about cash generation quality.
  • high
    Extreme leverage ratio
    Debt/Equity of 3.05x signals heavy balance sheet leverage; negative FCF compounds refinancing risk if conditions tighten.
  • moderate
    Momentum quality score low
    ACCE Momentum score is just 17/100, the weakest sub-score, suggesting poor near-term price momentum despite strong fundamentals.
  • moderate
    Insider net selling
    Last 10 disclosed transactions show $0 buys vs $5.29M in sales; no insider conviction buying at current levels.

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

See pricing

Price

-55.0% · 1Y

Snapshot

Growth88Value47Quality82Momentum25Total61
Valuation
Trailing P/E
23.6x
Forward P/E
18.6x
PEG
0.43
P/B
7.37x
EV / Revenue
8.1x
Book value/sh
$20.44
Enterprise value
$579.2B
Profitability
ROE
41.2%
FCF yield
-5.31%
ROIC
8.1%
Health and risk
Debt / equity
3.05
Dividend yield
1.33%
Beta
1.73
Member ofACCE Smart Money